VCID Biomarkers Coordinating Center
VCID Biomarkers Coordinating Center
批准号:
10685010
负责人:
Steven M Greenberg
金额:
$125.12万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2025-06-30
关键词:
AddressAfrican AmericanAgeAge-associated memory impairmentAwardBiological MarkersBlood VesselsBrain DiseasesCOVID-19 pandemicCaucasiansCerebral small vessel diseaseClinicalCommunicationCommunity OutreachConsumptionDataDementiaEligibility DeterminationEnrollmentEnsureFeedbackGeneral HospitalsGoalsHispanicHuman ResourcesImpaired cognitionIndividualLearningMassachusettsMedical centerMicrovascular DysfunctionParticipantPerformancePhasePopulationPositioning AttributeProceduresProcessReportingResearchResourcesSideSiteSpecialistStructureTimeUnderrepresented PopulationsValidationVisitWorkbiomarker identificationcareerexperiencefollow-upimprovedmeetingsperformance siteprofessional atmospherereal time monitoringrecruitresearch studyresponseretention ratesatisfactiontooltrial readiness
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The MarkVCID initiative is responsible for executing one of NIND’s highest identified priorities for reducing the
contribution of cerebral small vessel disease (SVD) to cognitive impairment and dementia: selection and
validation of SVD biomarkers for use in VCID research and trials. MarkVCID2, the current phase of the
consortium, is structured as a single coordinating center (CC) based at Massachusetts General Hospital
(MGH) and nine performance sites comprised of 15 US medical centers. To accomplish MarkVCID2’s goal of
clinically validating selected SVD biomarkers for full readiness for trial application, each award site will be
required to enroll at least 200 individuals meeting MarkVCID2 eligibility criteria over two years and retain them
for annual follow-up visits over three years. The enrolled population will be required at a minimum to include
adequate numbers of African American, Hispanic, and Caucasian individuals to ensure generalizability of the
findings to typically underrepresented populations as well as adequate numbers of subjects across the spans
of age and cognitive impairment potentially suitable for SVD trials.
The COVID19 pandemic has posed considerable barriers to meeting these ambitious goals, particularly for
recruitment in the typically underrepresented populations where obstacles to research participation and staffing
shortages have the greatest negative impact. The current proposal seeks to overcome these challenges by
equipping the MGH CC to serve as a central core of resources for site recruitment and retention of the targeted
diverse subject groups. We propose to establish two key new positions at the CC: a Recruitment and Retention
Project Manager and a Data and Reporting Specialist. The Project Manager will serve as the central
coordinator of recruitment and retention strategies with focus on underrepresented populations: identifying,
disseminating, and customizing best practices, recruitment materials, and lessons learned from targeted
community outreach initiatives. The Data and Reporting Specialist will develop and deploy processes at the
CC for real-time monitoring and communication to sites of actionable recruitment and retention data that can
be used to guide strategy, allocate effort, and avoid the burden of developing their own tracking tools.
By centralizing the demanding and time-consuming processes of identifying successful recruitment and
retention strategies and real-time tracking of recruitment/retention diversity, these two positions will take
substantial burden off site personnel and work against the increasingly prevalent negative feedback loop of
stressful work environments causing loss of site personnel. These will be sustainable positions built on the
expertise accumulated by the MGH CC. By substantially reducing duplicative work, the added positions will
allow sites to redirect their staff to on-the-ground recruitment and study visit procedures. We anticipate that the
resultant improvement in site working conditions will improve career satisfaction and retention of experienced
site staff and ultimately MarkVCID2’s recruitment and retention performance.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.cccb.2021.100033
发表时间:
2021
期刊:
Cerebral circulation - cognition and behavior
影响因子:
--
作者:
[Hainsworth AH, Elahi FM, Corriveau RA]
通讯作者:
Corriveau RA
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
-
批准号:10709862
-
项目类别:
-
资助金额:$1395.49万
-
财政年份:2019
-
负责人:Steven M Greenberg
-
依托单位:
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
-
批准号:9918026
-
项目类别:
-
资助金额:$502.66万
-
财政年份:2019
-
负责人:Steven M Greenberg
-
依托单位:
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
-
批准号:10021035
-
项目类别:
-
资助金额:$1109.24万
-
财政年份:2019
-
负责人:Steven M Greenberg
-
依托单位:
DISCOVERY: Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
-
批准号:10241401
-
项目类别:
-
资助金额:$1405.9万
-
财政年份:2019
-
负责人:Steven M Greenberg
-
依托单位:
Harvard Partners Neurology NEXT Clinical Trial Site
-
批准号:10223444
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2018
-
负责人:Steven M Greenberg
-
依托单位:
VCID Biomarker's Coordinating Center
-
批准号:9355480
-
项目类别:
-
资助金额:$127.68万
-
财政年份:2016
-
负责人:Steven M Greenberg
-
依托单位:
VCID Biomarker's Coordinating Center
-
批准号:9516183
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2016
-
负责人:Steven M Greenberg
-
依托单位:
VCID Biomarker's Coordinating Center
-
批准号:9271613
-
项目类别:
-
资助金额:$128.25万
-
财政年份:2016
-
负责人:Steven M Greenberg
-
依托单位:
Harvard Partners Neurology NEXT Clinical Trial Site
-
批准号:8242158
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2011
-
负责人:Steven M Greenberg
-
依托单位:
Harvard Partners Neurology NEXT Clinical Trial Site
-
批准号:8867304
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2011
-
负责人:Steven M Greenberg
-
依托单位:
Harvard Partners Neurology NEXT Clinical Trial Site
-
批准号:8737321
-
项目类别:
-
资助金额:$32.67万
-
财政年份:2011
-
负责人:Steven M Greenberg
-
依托单位:
Harvard Partners Neurology NEXT Clinical Trial Site
-
批准号:9293407
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2011
-
负责人:Steven M Greenberg
-
依托单位:
Harvard Partners Neurology NEXT Clinical Trial Site
-
批准号:8547117
-
项目类别:
-
资助金额:$24.22万
-
财政年份:2011
-
负责人:Steven M Greenberg
-
依托单位:
Harvard Partners Neurology NEXT Clinical Trial Site
-
批准号:8338432
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2011
-
负责人:Steven M Greenberg
-
依托单位:
Early Detection of Cerebral Amyloid Angiopathy
-
批准号:7946057
-
项目类别:
-
资助金额:$50.71万
-
财政年份:2010
-
负责人:Steven M Greenberg
-
依托单位:
Early Detection of Cerebral Amyloid Angiopathy
-
批准号:8495434
-
项目类别:
-
资助金额:$44.77万
-
财政年份:2010
-
负责人:Steven M Greenberg
-
依托单位:
Early Detection of Cerebral Amyloid Angiopathy
-
批准号:8117562
-
项目类别:
-
资助金额:$46.36万
-
财政年份:2010
-
负责人:Steven M Greenberg
-
依托单位:
Early Detection of Cerebral Amyloid Angiopathy
-
批准号:8287078
-
项目类别:
-
资助金额:$46.3万
-
财政年份:2010
-
负责人:Steven M Greenberg
-
依托单位:
Early Detection of Cerebral Amyloid Angiopathy
-
批准号:8677981
-
项目类别:
-
资助金额:$46.02万
-
财政年份:2010
-
负责人:Steven M Greenberg
-
依托单位:
Clinical, Radiographic, and Genetic Associations in Cerebral Amyloid Angiopathy
-
批准号:7281748
-
项目类别:
-
资助金额:$18.14万
-
财政年份:2006
-
负责人:Steven M Greenberg
-
依托单位:
海外基金